Ascension’s $3.9B AmSurg Deal Signals New ASC Antitrust Era
Ascension completed its $3.9 billion acquisition of AmSurg on June 4, 2026, expanding its ambulatory surgery center network from 58 to more than 300 facilities across 34 states — making it one of the largest ASC operators in the U.S. alongside Tenet’s USPI and SCA Health. The FTC required Ascension to divest seven ASCs in Tennessee, Florida, Oklahoma, Texas, and Kansas to preserve local competition, with six going to SCA Health (an Optum subsidiary) and one transferring to a physician group. For 10 years, Ascension must give the FTC advance notice before acquiring any ASCs near the divested markets. The consent order marks the first time the FTC has scrutinized an ASC deal at this scale, signaling new antitrust attention on outpatient surgery consolidation.
This deal signals that ASC consolidation now draws the same local-market antitrust scrutiny long applied to hospitals and payers — PE-backed and health-system ASC platforms pursuing roll-ups should expect longer FTC timelines, mandated divestitures, and post-close monitoring in concentrated metros.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.
Why did the FTC require Ascension to divest 7 ASCs in its $3.9B AmSurg deal?
The FTC’s June 2026 consent order found the deal would otherwise threaten competition in five states — Tennessee, Florida, Oklahoma, Texas, and Kansas. Six of the divested centers went to SCA Health (an Optum subsidiary) and one transferred to a physician group with an existing minority stake.
How many ASCs does Ascension now operate after the AmSurg acquisition?
Ascension’s ASC footprint grew from 58 centers to more than 300 across 34 states, placing it among the largest ASC operators nationally alongside Tenet’s United Surgical Partners International and SCA Health.
What ongoing FTC obligations does Ascension face after closing the AmSurg deal?
For 10 years, Ascension must provide the FTC advance notice before acquiring any ASCs in metro areas surrounding the divested facilities. A monitor will also oversee compliance with transition and divestiture obligations for up to one year.